Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Exposure to Plasmodium falciparum infected mosquitoes is a Controlled Human Malaria Infection (CHMI) methodology developed and utilized by Radboud University Medical Center. In this model, healthy, malaria-naïve volunteers are deliberately exposed to the bites of five laboratory-reared Anopheles mosquitoes carrying Plasmodium falciparum sporozoites. This procedure is designed to induce a predictable and controlled malaria infection, serving as a rigorous challenge model to evaluate the preliminary efficacy of malaria vaccine candidates and antimalarial drugs in Phase IIa clinical trials. The model utilizes various parasite isolates, including the standard NF54 strain and genetically diverse isolates like PfA and PfB, to study heterologous protection and immunological mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on exposure to Plasmodium falciparum infected mosquitoes.